Search
for
Sort by
Research 571–600 of 1000+
- A phase I safety study of topical calcitriol (BPM 31543) for the prevention of chemotherapy-induced alopecia (CIA).
- Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review
- Solid Lipid Nanoparticle–Loaded Acanthus ebracteatus Vahl. Extract for Androgenic Alopecia Treatment: A Randomized, Controlled, Open‐Label, Four‐Arm Parallel‐Group Clinical Study
- Comparison of the Efficacy of 5% Dapsone Gel and 1% Clindamycin Phosphate Gel in the Treatment of Mild to Moderate Acne Vulgaris
- 58-Year-Old Female with Diffuse Thinning of the Hair
- Management of hypotrichosis of the eyelashes: Focus on bimatoprost
- Hair analysis of formoterol as a novel tool to assess long‐term inhalation medication adherence: Data from the TRICOLON trial
- From Eye Care to Hair Growth: Bimatoprost
- Fixed-dose combination PRO 160/120 of sabal and urtica extracts improves nocturia in men with LUTS suggestive of BPH: re-evaluation of four controlled clinical studies
- The Comparative Safety of Epirubicin and Cyclophosphamide versus Docetaxel and Cyclophosphamide in Lymph Node-Negative, HR-Positive, HER2-Negative Breast Cancer (ELEGANT): A Randomized Trial
- Dutasteride: A Review of its Use in the Management of Prostate Disorders
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- Scalp hair regrowth is associated with improvements in health-related quality of life and psychological symptoms in patients with severe alopecia areata: results from two randomized controlled trials
- Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata
- Adipose tissue in the treatment of androgenic alopecia.
- EEMCO Guidance for the Assessment of Hair Shedding and Alopecia
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm
- Taxane-induced alopecia: A historical review of patients with ovarian or breast cancer treated with with paclitaxel, docetaxel or paclitaxel poliglumex
- [Finasteride: a new drug for the treatment of male hirsutism and androgenetic alopecia?].
- Phase 2, double-blind, randomized, placebo-controlled study of the safety and efficacy of elagolix in women with polycystic ovary syndrome
- A systematic review of clinical evidence on the efficacy and safety of conditioned media, platelet-rich fibrin, stromal vascular fraction, extracellular vesicles, and stem cells in androgenetic alopecia
- Preclinical and Clinical Efficacy of a Green Tea, Bamboo, and Selenium Supplement for the Management of Acute Telogen Effluvium in Women
- Major randomized clinical studies of alopecia treatment with platelet-rich plasma: a systematic review
- Histopathology of alopecia areata, acute and chronic: Why is it important to the clinician?
- The state‐of‐the‐art in the management of androgenetic alopecia: A review of new therapies and treatment algorithms
- Evaluation of platelet‐rich plasma plus basic fibroblast growth factor combined with minoxidil in the treatment of androgenetic alopecia: A randomized controlled trial
- Reply to: “Tofacitinib for the treatment of severe alopecia areata and variants”
- Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer
- Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets